Close
Help





JOURNAL

Clinical Medicine Reviews in Therapeutics

A Review of the Safety and Efficacy of Sugammadex in Anesthetic Practice

Submit a Paper


Clinical Medicine Reviews in Therapeutics 2012:4 97-108

Review

Published on 05 Jul 2012

DOI: 10.4137/CMRT.S3292


Further metadata provided in PDF

Download Article PDF


Sign up for email alerts to receive notifications of new articles published in Clinical Medicine Reviews in Therapeutics

Abstract

Sugammadex, the first in a novel class of medications termed selective relaxant binding agents, was developed to rapidly and completely encapsulate aminosteroid neuromuscular blocking agents, thus removing them from the neuromuscular junction. When used properly, sugammadex has the potential to decrease the incidence of residual neuromuscular block and it's associated complications, as well as, avoid the side effects associated with cholinesterase inhibitors. Sugammadex may also have a role in the management of patients with difficult airways and rocuronium- induced anaphylaxis. Currently available in over 70 countries worldwide, fears of hypersensitivity reactions have delayed it's release in the United States. The article looks to examine the role of sugammadex in anesthesia and detail its pharmacologic profile.



Downloads

RIS citation   (ENDNOTE, REFERENCE MANAGER, PROCITE, REFWORKS)

BibTex citation   (BIBDESK, LATEX)





Quick Links


New article and journal news notification services